(Q44607992)

English

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis

scientific article published on 24 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Hiroharu Yamashita

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Hironori Yamaguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Joji Kitayama

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hironori Ishigami

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shigenobu Emoto

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Toshiaki Watanabe

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

24 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3354-3358

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

21 January 2018

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28204

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44607992&oldid=2086013854"